share_log

Panbela Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

Panbela Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

Panbela Therapeutics | PRER14A：初步修订代理权征集材料
美股SEC公告 ·  04/26 16:45

Moomoo AI 已提取核心信息

Panbela Therapeutics, Inc. has filed a revised preliminary proxy statement with the SEC, amending and superseding the original proxy statement filed on April 4, 2024, in connection with the company's rescheduled Special Meeting of Stockholders. The meeting, originally set for May 3, 2024, has been moved to May 28, 2024, with a new record date of April 24, 2024, for stockholder eligibility to vote. The proxy statement details the rescheduling and the issuance of one share of Series A Preferred Stock on April 23, 2024, with specific voting rights. The Special Meeting's agenda includes a proposal to approve a reverse stock split of the company's common stock, with a ratio range between 1-for-10 and 1-for-45, as determined by the board. Additionally, the meeting will consider the approval...Show More
Panbela Therapeutics, Inc. has filed a revised preliminary proxy statement with the SEC, amending and superseding the original proxy statement filed on April 4, 2024, in connection with the company's rescheduled Special Meeting of Stockholders. The meeting, originally set for May 3, 2024, has been moved to May 28, 2024, with a new record date of April 24, 2024, for stockholder eligibility to vote. The proxy statement details the rescheduling and the issuance of one share of Series A Preferred Stock on April 23, 2024, with specific voting rights. The Special Meeting's agenda includes a proposal to approve a reverse stock split of the company's common stock, with a ratio range between 1-for-10 and 1-for-45, as determined by the board. Additionally, the meeting will consider the approval of adjournments if necessary to solicit more proxies in the event of insufficient votes or lack of quorum. Stockholders are urged to use the new proxy card provided for their votes to be counted. The proxy statement and related materials are available online, and stockholders must register by May 25, 2024, to attend the virtual meeting.
Panbela Therapeutics, Inc.已向美国证券交易委员会提交了经修订的初步委托书，修改并取代了2024年4月4日提交的与该公司重新安排的股东特别会议有关的原始委托书。该会议原定于2024年5月3日举行，现已推迟到2024年5月28日，股东投票资格的新纪录日期为2024年4月24日。委托书详细说明了2024年4月23日A系列优先股的改期和发行情况，并附有特定投票权。特别会议的议程包括一项批准公司普通股反向拆分的提案，由董事会决定，该比率介于1比10和1比45之间。此外，如有必要，会议将考虑批准休会，以便在选票不足或法定人数不足的情况下争取更多的代理人。敦促股东使用为计算选票而提供的新代理卡。委托书和相关材料可在线获取，股东必须在2024年5月25日之前注册才能参加虚拟会议。
Panbela Therapeutics, Inc.已向美国证券交易委员会提交了经修订的初步委托书，修改并取代了2024年4月4日提交的与该公司重新安排的股东特别会议有关的原始委托书。该会议原定于2024年5月3日举行，现已推迟到2024年5月28日，股东投票资格的新纪录日期为2024年4月24日。委托书详细说明了2024年4月23日A系列优先股的改期和发行情况，并附有特定投票权。特别会议的议程包括一项批准公司普通股反向拆分的提案，由董事会决定，该比率介于1比10和1比45之间。此外，如有必要，会议将考虑批准休会，以便在选票不足或法定人数不足的情况下争取更多的代理人。敦促股东使用为计算选票而提供的新代理卡。委托书和相关材料可在线获取，股东必须在2024年5月25日之前注册才能参加虚拟会议。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间